Healthcare
Diagnostics
Revenue grew 19% YoY to INR 8bn, ahead of estimates, driven by volume growth and mix optimization, with EBITDA margin expanding 230bps YoY to 31%.
Ratings and target prices as published by each firm. Each summary condenses that firm's stated view in its own note and is attributed to it; no report text is reproduced.
